Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness

Morens, David M., Taubenberger, Jeffery K., Fauci, Anthony S.·2008·The Journal of Infectious Diseases

Cited by (1,629)

Items 201–300 of 1,629

  1. Confronting the next influenza pandemic with anti‐inflammatory and immunomodulatory agents: why they are needed and how they might work
    David S. Fedson · 2009 · Influenza and Other Respiratory Viruses
  2. New treatments for influenza
    Sailen Barik · 2012 · BMC Medicine
  3. Maternal morbidity and mortality from severe sepsis: a national cohort study
    C. Acosta, D. Harrison, K. Rowan, D. N. Lucas, J. Kurinczuk, M. Knight · 2016 · BMJ Open
  4. Seasonal FluMist Vaccination Induces Cross-Reactive T Cell Immunity against H1N1 (2009) Influenza and Secondary Bacterial Infections
    Keer Sun, Jianqiang Ye, Daniel Roberto Perez, Dennis W. Metzger · 2010 · The Journal of Immunology
  5. Towards multiscale modeling of influenza infection
    Lisa N. Murillo, Michael S. Murillo, Alan S. Perelson · 2013 · Journal of Theoretical Biology
  6. Overview on the Prevalence of Fungal Infections, Immune Response, and Microbiome Role in COVID-19 Patients
    Maryam Roudbary, Sunil Kumar, Awanish Kumar, Lucia Černáková, Fatemeh Nikoomanesh, Celia Fortuna Rodrigues · 2021 · Journal of Fungi
  7. Emerging Infectious Diseases in 2012: 20 Years after the Institute of Medicine Report
    David Michael Morens, Anthony S. Fauci · 2012 · mBio
  8. A Postinfluenza Model of<i>Staphylococcus aureus</i>Pneumonia
    Lee, Mei‐Ho, Arrecubieta, Carlos, Martin, Francis J., Prince, Alice, Borczuk, Alain C., Lowy, Franklin D. · 2010 · The Journal of Infectious Diseases
  9. Combination strategies for pandemic influenza response - a systematic review of mathematical modeling studies
    Vernon J. Lee, David Chien Lye, Annelies Wilder‐Smith · 2009 · BMC Medicine
  10. Mechanisms of Bacterial Superinfection Post-influenza: A Role for Unconventional T Cells
    Christophe Paget, François Trottein · 2019 · Frontiers in Immunology
  11. Respiratory Barrier as a Safeguard and Regulator of Defense Against Influenza A Virus and Streptococcus pneumoniae
    Kim S. LeMessurier, Meenakshi Tiwary, Nicholas P. Morin, Amali Eashani Samarasinghe · 2020 · Frontiers in Immunology
  12. Host Defense and the Airway Epithelium: Frontline Responses That Protect against Bacterial Invasion and Pneumonia
    Nicholas A. Eisele, Deborah M. Anderson · 2011 · Journal of Pathogens
  13. How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count
    Marc Lipsitch, Frederick G. Hayden, Benjamin John Cowling, Gabriel Matthew Leung · 2009 · The Lancet
  14. Age- and Sex-Specific Mortality Associated With the 1918–1919 Influenza Pandemic in Kentucky
    Cecile G. Viboud, Jana Eisenstein, Ann H. Reid, Thomas A. Janczewski, David Michael Morens, Jeffery K. Taubenberger · 2012 · The Journal of Infectious Diseases
  15. Bacterial Superinfections Among Persons With Coronavirus Disease 2019: A Comprehensive Review of Data From Postmortem Studies
    Cornelius Joseph Clancy, Ilan Steven Schwartz, Brittany Kula, M. Hong Nguyen · 2021 · Open Forum Infectious Diseases
  16. Imaging Findings in a Fatal Case of Pandemic Swine-Origin Influenza A (H1N1)
    Daniel J. Mollura, Deborah S. Asnis, Robert Crupi, Rick Conetta, David S. Feigin, Mike Bray, Jeffery K. Taubenberger, David A. Bluemke · 2009 · American Journal of Roentgenology
  17. Effects of Influenza on Alveolar Macrophage Viability Are Dependent on Mouse Genetic Strain
    Danielle Califano, Yoichi Furuya, Dennis W. Metzger · 2018 · The Journal of Immunology
  18. Diminished immune responses with aging predispose older adults to common and uncommon influenza complications
    Spencer R. Keilich, Jenna M. Bartley, Laura Haynes · 2019 · Cellular Immunology
  19. Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19
    George R. Thompson, Oliver A. Cornely, Peter G. Pappas, Thomas F. Patterson, Martin Hoenigl, Jeffrey D. Jenks, Cornelius Joseph Clancy, M. Hong Nguyen · 2020 · Open Forum Infectious Diseases
  20. Increased IL‐10‐producing regulatory T cells are characteristic of severe cases of COVID‐19
    Julika Neumann, Teresa Prezzemolo, Lore Vanderbeke, Carlos P. Roca, Margaux Gerbaux, Silke Janssens, Mathijs Willemsen, Oliver T. Burton, Pierre Van Mol, Yannick Van Herck et al. · 2020 · Clinical & Translational Immunology
  21. Predictors and outcomes of healthcare-associated infections in COVID-19 patients
    Gagan Kumar, Alex Adams, Martin Herrera, Erine Raybon-Rojas, Vartika Singh, Ankit Sakhuja, Mark Meersman, Drew Dalton, Shravan Kethireddy, Rahul S. Nanchal et al. · 2020 · International Journal of Infectious Diseases
  22. Pandemic Influenza: An Inconvenient Mutation
    Scott P. Layne, Arnold S. Monto, Jeffery K. Taubenberger · 2009 · Science
  23. Association of the CT values of real‐time PCR of viral upper respiratory tract infection with clinical severity, Kenya
    James A. Fuller, M. Kariuki Njenga, Godfrey Bigogo · 2013 · Journal of Medical Virology
  24. Selective detections of single-viruses using solid-state nanopores
    Akihide Arima, Makusu Tsutsui, Ilva Hanun Harlisa, Takeshi Yoshida, Masayoshi Tanaka, Kazumichi Yokota, Wataru Tonomura, Masateru Taniguchi, Mina Okochi, Takashi Washio et al. · 2018 · Scientific Reports
  25. Community-acquired pneumonia due to pandemic A(H1N1)2009 influenzavirus and methicillin resistant Staphylococcus aureus co-infection.
    Murray, Ronan J., Robinson, James O., White, Jodi N., Hughes, Frank, Coombs, Geoffrey W., Pearson, Julie C., Tan, Hui-Leen, Chidlow, Glenys, Williams, Simon, Christiansen, Keryn J. et al. · 2010 · PLoS ONE
  26. Etiology of community acquired pneumonia among children in India: prospective, cohort study
    Joseph Lazar Mathew, Sunit Chandra Singhi, Pallab Ray, Eva Hagel, Shanie Saghafian‐Hedengren, Arun Bansal, Sofia Eriksson Ygberg, Kushaljit Singh Sodhi, B V Ravi Kumar, Anna Nilsson · 2015 · Journal of Global Health
  27. Parapneumonic Empyema Deaths during Past Century, Utah
    Jeffrey M. Bender, Krow Ampofo, Xiaoming Sheng, Andrew T. Pavia, Lisa Cannon‐Albright, Carrie L. Byington · 2008 · Emerging infectious diseases
  28. The amazing innate immune response to influenza A virus infection
    Shweta Tripathi, Mitchell R. White, Kevan L. Hartshorn · 2013 · Innate Immunity
  29. Toll-Like Receptor 2 Mediates Fatal Immunopathology in Mice During Treatment of Secondary Pneumococcal Pneumonia Following Influenza
    Åsa Karlström, Sarah M. Heston, Kelli Lynn Boyd, ELAINE I. TUOMANEN, Jonathan A. McCullers · 2011 · The Journal of Infectious Diseases
  30. Combined Action of Influenza Virus and Staphylococcus aureus Panton–Valentine Leukocidin Provokes Severe Lung Epithelium Damage
    Silke Niemann, Christina Ehrhardt, Eva Medina, Kathrin Warnking, Lorena P. N. Tuchscherr, Vanessa Heitmann, Stephan Ludwig, Georg Peters, Bettina Löffler · 2012 · The Journal of Infectious Diseases
  31. Intensive care management of influenza-associated pulmonary aspergillosis
    Koehler, P., Bassetti, M., Kochanek, M., Shimabukuro-Vornhagen, A., Cornely, O.A. · 2019 · Clinical Microbiology and Infection
  32. Efficacy of Maternal Influenza Vaccination Against All-Cause Lower Respiratory Tract Infection Hospitalizations in Young Infants: Results From a Randomized Controlled Trial
    Marta Coelho Nunes, Clare Cutland, Stephanie Jones, Sarah Downs, Adriana Weinberg, Justin R. Ortiz, Kathleen Maletic Neuzil, Eric A. F. Simões, Keith P. Klugman, Shabir Ahmed Madhi · 2017 · Clinical Infectious Diseases
  33. Interaction between the nasal microbiota and S. pneumoniae in the context of live-attenuated influenza vaccine
    Wouter A. A. de Steenhuijsen Piters, Simon P. Jochems, Elena Mitsi, Jamie Rylance, Sherin Pojar, Elissavet Nikolaou, Esther L. German, Mark Holloway, Beatriz F. Carniel, Mei Ling J. N. Chu et al. · 2019 · Nature Communications
  34. Staphylococcus aureus Bacteremia in Patients Infected With COVID-19: A Case Series
    Jaclyn A. Cusumano, Amy C. Dupper, Yesha Malik, Elizabeth Marie Gavioli, Jaspreet Banga, Ana Berbel Caban, Devika Nadkarni, Ajay Obla, Chirag V Vasa, Dana Mazo et al. · 2020 · Open Forum Infectious Diseases
  35. Chinchilla as a robust, reproducible and polymicrobial model of otitis media and its prevention
    Lauren O. Bakaletz · 2009 · Expert Review of Vaccines
  36. Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell Types
    Elena Tomasello, Émeline Pollet, Thien‐Phong Vu Manh, Gilles Uzé, Marc Dalod · 2014 · Frontiers in Immunology
  37. Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09
    Amanda Bradley-Stewart, Lisa Jolly, Walt E. Adamson · 2013 · Journal of Clinical Virology
  38. Deep learning of contagion dynamics on complex networks
    Charles Murphy, Edward Laurence, Antoine Allard · 2021 · Nature Communications
  39. Timing and causes of death in severe COVID-19 patients
    Charles de Roquetaillade, Swann Bredin, Jean-Baptiste Lascarrou, Thibaud Soumagne, Mariana Cojocaru, Benjamin Glenn Chousterman, Maxime Leclerc, Albin Gouhier, Gaël Piton, Frédéric Pène et al. · 2021 · Critical Care
  40. Coinfections with Bacteria, Fungi, and Respiratory Viruses in Patients with SARS-CoV-2: A Systematic Review and Meta-Analysis
    Saad Alhumaid, Abbas Saleh Al Mutair, Zainab Al Alawi, Abeer M. Alshawi, Salamah A. Alomran, Mohammed S. Almuhanna, Anwar A. Almuslim, Ahmed H. Bu Shafia, Abdullah Falah Alotaibi, Gasmelseed Y. Ahmed et al. · 2021 · Pathogens
  41. The microbiome: an integral player in immune homeostasis and inflammation in the respiratory tract
    Olaf Perdijk, Rossana Azzoni, Benjamin J. Marsland · 2023 · Physiological Reviews
  42. Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors
    Magid Awadalla, Doll Lauren Alexandra Golden, Syed Mahmood, Raza M. Alvi, Nathaniel David Mercaldo, Malek Z. O. Hassan, Dahlia Banerji, Adam Rokicki, Connor P. Mulligan, Sean Murphy et al. · 2019 · Journal for ImmunoTherapy of Cancer
  43. Airway immune homeostasis and implications for influenza-induced inflammation
    Robert J. Snelgrove, Alexandra Godlee, Tracy Hussell · 2011 · Trends in Immunology
  44. Age and testosterone mediate influenza pathogenesis in male mice
    Landon G. vom Steeg, Meghan S. Vermillion, Olivia J. Hall, Ornob Alam, Ross McFarland, Haolin Chen, Barry R. Zirkin, Sabra L. Klein · 2016 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  45. The psychobiological links between chronic stress‐related diseases, periodontal/peri‐implant diseases, and wound healing
    Ann M. Decker, Yvonne Lorraine Kapila, Hom‐Lay Wang · 2021 · Periodontology 2000
  46. The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles
    Tarabichi, Y., Li, K., Hu, S., Nguyen, C., Wang, X., Elashoff, D., Saira, K., Frank, Bryan, Bihan, Monika, Ghedin, E. et al. · 2015 · Microbiome
  47. Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination.
    M.A. Julie Westerink, Harry W. Schroeder, Moon H. Nahm · 2012 · Europe PMC (PubMed Central)
  48. What is the Role of Respiratory Viruses in Community-Acquired Pneumonia?
    Andrew T. Pavia · 2012 · Infectious Disease Clinics of North America
  49. Pathogenesis ofStaphylococcus aureusnecrotizing pneumonia: the role of PVL and an influenza coinfection
    Bettina Löffler, Silke Niemann, Christina Ehrhardt, Dagmar Horn, Christian Lanckohr, Gérard Lina, Stephan Ludwig, Georg Peters · 2013 · Expert Review of Anti-infective Therapy
  50. The role of influenza in the severity and transmission of respiratory bacterial disease
    Michael Joseph Mina, Keith P. Klugman · 2014 · The Lancet Respiratory Medicine
  51. Poly I:C Enhances Susceptibility to Secondary Pulmonary Infections by Gram-Positive Bacteria
    Xiaoli Tian, Feng Xu, Wing Yi Lung, Cherise Meyerson, Amir A. Ghaffari, Genhong Cheng, Jane C. Deng · 2012 · PLoS ONE
  52. Immunosenescence: Implications for vaccination programmes in adults
    Pierre Olivier Lang, Sheila Govind, Jean Pierre Michel, Richard Aspinall, Wayne A. Mitchell · 2011 · Maturitas
  53. A Centenary Tale of Two Pandemics: The 1918 Influenza Pandemic and COVID-19, Part I
    David Michael Morens, Jeffery K. Taubenberger, Anthony S. Fauci · 2021 · American Journal of Public Health
  54. Association of 2009 Pandemic Influenza A (H1N1) Infection and Increased Hospitalization With Parapneumonic Empyema in Children in Utah
    Krow Ampofo, Amy Herbener, Anne J. Blaschke, Caroline Heyrend, Mark A. Poritz, Kent E. Korgenski, Robert T. Rolfs, Seema Jain, Maria da Glória Carvalho, Fabiana Cristina Pimenta et al. · 2010 · The Pediatric Infectious Disease Journal
  55. Reconstruction of the 1918 Influenza Virus: Unexpected Rewards from the Past
    Jeffery K. Taubenberger, David Baltimore, Peter C. Doherty, Howard Markel, David Michael Morens, Robert G. Webster, Ian A. Wilson · 2012 · mBio
  56. The Mother of All Pandemics Is 100 Years Old (and Going Strong)!
    David Michael Morens, Jeffery K. Taubenberger · 2018 · American Journal of Public Health
  57. Navigating the Uncertainties of COVID-19–Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis
    Frédéric Lamoth, Russell Edward Lewis, Thomas J. Walsh, Dimitrios P. Kontoyiannis · 2021 · The Journal of Infectious Diseases
  58. The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding
    Li Qi, John C. Kash, Vivien G. Dugan, Brett W. Jagger, Yuk-Fai Lau, Zhong-Mei Sheng, Erika C. Crouch, Kevan L. Hartshorn, Jeffery K. Taubenberger · 2011 · Virology
  59. Randomized, Controlled Trial of a 13-Valent Pneumococcal Conjugate Vaccine Administered Concomitantly with an Influenza Vaccine in Healthy Adults
    Robert W. Frenck, Alejandra Gurtman, John Rubino, William Smith, Martin van Cleeff, Deepthi A. Jayawardene, Peter C. Giardina, Emilio A. Emini, William C. Gruber, Daniel A. Scott et al. · 2012 · Clinical and Vaccine Immunology
  60. The role of IL-27 in susceptibility to post-influenza Staphylococcus aureus pneumonia
    Keven Mara Robinson, Benjamin Lee, Erich V. Scheller, Sivanarayana Mandalapu, Richard I. Enelow, Jay K. Kolls, John F. Alcorn · 2015 · Respiratory Research
  61. Death from 1918 pandemic influenza during the First World War: a perspective from personal and anecdotal evidence
    Peter C. Wever, Leo van Bergen · 2014 · Influenza and Other Respiratory Viruses
  62. Bacterial and viral infections and related inflammatory responses in chronic obstructive pulmonary disease
    Silvestro Ennio D’Anna, Mauro Maniscalco, Francesco Cappello, Mauro Carone, Andréa Motta, Bruno Balbi, Fabio Luigi Massimo Ricciardolo, Gaetano Caramori, Antonino Di Stefano · 2020 · Annals of Medicine
  63. Role of surfactant protein A and D SP-A and SP-D in human antiviral host defense
    Kevan L. Hartshorn · 2009 · Frontiers in Bioscience-Scholar
  64. Benefits and Effectiveness of Administering Pneumococcal Polysaccharide Vaccine With Seasonal Influenza Vaccine: An Approach for Policymakers
    Shawn Gilchrist, Angeline Nanni, Orin S. Levine · 2012 · American Journal of Public Health
  65. Influenza A virus-induced release of interleukin-10 inhibits the anti-microbial activities of invariant natural killer T cells during invasive pneumococcal superinfection
    Adeline Barthélémy, Stoyan Ivanov, Josette Fontaine, Daphnée Soulard, Hicham Bouabe, Christophe Paget, Christelle Faveeuw, François Trottein · 2016 · Mucosal Immunology
  66. Host‐pathogen kinetics during influenza infection and coinfection: insights from predictive modeling
    Amber M. Smith · 2018 · Immunological Reviews
  67. Effect of 1918 PB1-F2 Expression on Influenza A Virus Infection Kinetics
    Amber M. Smith, Frederick R. Adler, Julie McAuley, Ryan N. Gutenkunst, Ruy Miguel Ribeiro, Jonathan A. McCullers, Alan S. Perelson · 2011 · PLoS Computational Biology
  68. Salicylates and Pandemic Influenza Mortality, 1918–1919 Pharmacology, Pathology, and Historic Evidence
    Karen M. Starko · 2009 · Clinical Infectious Diseases
  69. Influenza Virus Infection Induces Platelet-Endothelial Adhesion Which Contributes to Lung Injury
    Michael G. Sugiyama, Asela Gamage, Roman E. Zyla, Susan M. Armstrong, Suzanne L. Advani, Andrew Advani, Changsen Wang, Warren L. Lee · 2015 · Journal of Virology
  70. High‐throughput RNA sequencing of a formalin‐fixed, paraffin‐embedded autopsy lung tissue sample from the 1918 influenza pandemic
    Yongli Xiao, John C. Kash, Stephen B. Beres, Zong‐Mei Sheng, James M. Musser, Jeffery K. Taubenberger · 2012 · The Journal of Pathology
  71. Adaptive Vaccination Strategies to Mitigate Pandemic Influenza: Mexico as a Case Study
    Gerardo Chowell, Cecile G. Viboud, Xiaohong Wang, Stefano Bertozzi, Mark A. Miller · 2009 · PLoS ONE
  72. Viral–bacterial interactions in the respiratory tract
    Carla Bellinghausen, Gernot G. U. Rohde, Paul H. M. Savelkoul, Emiel F.�M. Wouters, Frank R. M. Stassen · 2016 · Journal of General Virology
  73. MultiDrug-Resistant 2009 Pandemic Influenza A(H1N1) Viruses Maintain Fitness and Transmissibility in Ferrets
    Matthew James Memoli, Anne Sally Davis, Kathleen Proudfoot, Daniel S. Chertow, Rachel J. Hagey, Tyler Bristol, Jeffery K. Taubenberger · 2010 · The Journal of Infectious Diseases
  74. Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: A single-center retrospective study
    Paul Loubet, Guillaume Voiriot, Nadhira Houhou‐Fidouh, Mathilde Neuville, Lila Bouadma, François-Xavier Lescure, Diane Descamps, JF Timsit, Yazdan Yazdanpanah, Benoît Visseaux · 2017 · Journal of Clinical Virology
  75. Targeting TLR4 Signaling to Blunt Viral-Mediated Acute Lung Injury
    Kari Ann Shirey, Jorge C. G. Blanco, Stefanie N. Vogel · 2021 · Frontiers in Immunology
  76. Characterization of the upper respiratory tract microbiomes of patients with pandemic H1N1 influenza
    Chaban, Bonnie, Albert, Arianne, Links, Matthew G., Gardy, Jennifer, Tang, Patrick, Hill, Janet E. · 2013 · PLoS ONE
  77. A Mouse Model of Lethal Synergism Between Influenza Virus and Haemophilus influenzae
    Lian Ni Lee, Peter B. Dias, Dongun Han, Sorah Yoon, Ashley Shea, Vladislav Zakharov, David M. Parham, Sally R. Sarawar · 2009 · American Journal Of Pathology
  78. Influenza Infectious Dose May Explain the High Mortality of the Second and Third Wave of 1918–1919 Influenza Pandemic
    Ana Cristina Paulo, Margarida Correia‐Neves, Tiago Domingos, Alberto G. Murta, Jorge Pedrosa · 2010 · PLoS ONE
  79. Paradigm Shift in Antimicrobial Resistance Pattern of Bacterial Isolates during the COVID-19 Pandemic
    Vikas Saini, Charu Madhwani Jain, Narendra Pal Singh, Ahmad Alsulimani, Chhavi Gupta, Sajad Ahmad Dar, Shafiul Haque, Shukla Das · 2021 · Antibiotics
  80. The 1918 influenza pandemic hastened the decline of tuberculosis in the United States: An age, period, cohort analysis
    Andrew Noymer · 2011 · Vaccine
  81. The role of respiratory viruses in the etiology of bacterial pneumonia
    Kyu Han Lee, Aubree Gordon, Betsy Foxman · 2016 · Evolution Medicine and Public Health
  82. Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model
    Hao Wang, Desiree Anthony, Selcuk Yatmaz, Odilia L. C. Wijburg, Catherine Satzke, Bruce David Levy, Ross Vlahos, Steven Bozinovski · 2017 · Clinical Science
  83. Relationship between nasopharyngeal microbiota and patient’s susceptibility to viral infection
    Grégory Dubourg, Sophie Edouard, Didier Raoult · 2019 · Expert Review of Anti-infective Therapy
  84. The Implications of Zinc Therapy in Combating the COVID-19 Global Pandemic
    Nandeeta Samad, Temitayo Eniola Sodunke, Abdullahi Rabiu Abubakar, Iffat Jahan, Paras Sharma, Salequl Islam, Siddhartha Dutta, Mainul Haque · 2021 · Journal of Inflammation Research
  85. The Tie2-agonist Vasculotide rescues mice from influenza virus infection
    Michael G. Sugiyama, Susan M. Armstrong, Changsen Wang, David M. Hwang, Howard M. Leong-Poi, Andrew Advani, Suzanne L. Advani, Haibo Zhang, Katalin Szászi, Arata Tabuchi et al. · 2015 · Scientific Reports
  86. The Lung Immune Response to NontypeableHaemophilus influenzae(Lung Immunity to NTHi)
    Paul T. King, Roleen Sharma · 2015 · Journal of Immunology Research
  87. Postviral Complications
    Jason E. Prasso, Jane C. Deng · 2016 · Clinics in Chest Medicine
  88. CXCR1/2 Antagonism Is Protective during Influenza and Post-Influenza Pneumococcal Infection
    Luciana P. Tavares, Cristiana Couto Garcia, Marina Gomes Machado, Celso Martins Queiroz‐Junior, Adeline Barthélémy, François Trottein, Marilda Mendonça Siqueira, Laura Brandolini, Marcello Allegretti, Alexandre V. Machado et al. · 2017 · Frontiers in Immunology
  89. Influenza Infection Induces Alveolar Macrophage Dysfunction and Thereby Enables Noninvasive Streptococcus pneumoniae to Cause Deadly Pneumonia
    Atul K Verma, Shruti Bansal, Christopher D. Bauer, Abenaya Muralidharan, Keer Sun · 2020 · The Journal of Immunology
  90. The seasonality of pandemic and non-pandemic influenzas: the roles of solar radiation and vitamin D
    Asta Juzeniene, Li-Wei Ma, Mateusz Kwitniewski, Georgy A. Polev, Zoya Lagunova, Arne Dahlback, Johan E. Moan · 2010 · International Journal of Infectious Diseases
  91. Preventing and Treating Secondary Bacterial Infections with Antiviral Agents
    Jonathan A. McCullers · 2011 · Antiviral Therapy
  92. Cellular immune reactions in the lung
    Mike Hasenberg, Sabine Stegemann‐Koniszewski, Matthias Gunzer · 2012 · Immunological Reviews
  93. Differences in the Epidemiological Characteristics and Clinical Outcomes of Pandemic (H1N1) 2009 Influenza, Compared with Seasonal Influenza
    Kevin T. Shiley, G. Nadolski, Timothy J. Mickus, Neil O. Fishman, Ebbing Lautenbach · 2010 · Infection Control and Hospital Epidemiology
  94. Influenza vaccination is associated with reduced severity of community-acquired pneumonia
    Tessmer, A., Welte, T., Schmidt-Ott, R., Eberle, S., Barten, G., Suttorp, N., Schaberg, T. · 2011 · European Respiratory Journal
  95. Pandemic and post-pandemic Influenza A (H1N1) infection in critically ill patients
    Ignacio Martín‐Loeches, Emili Dı́az, Loreto Vidaur, Antoní Torres, César Laborda, Rosa María Granada, Juan Bonastre, Mar Martín, Josu Insausti, Ángel Arenzana et al. · 2011 · Critical Care
  96. Early nasopharyngeal microbial signature associated with severe influenza in children: a retrospective pilot study
    Langevin, Stanley, Pichon, Maxime, Smith, Elise, Morrison, Juliet, Bent, Zachary, Green, Richard, Barker, Kristi, Solberg, Owen, Gillet, Yves, Javouhey, Etienne et al. · 2017 · Journal of General Virology
  97. Role of procalcitonin and C-reactive protein in differentiation of mixed bacterial infection from 2009 H1N1 viral pneumonia: Mixed bacterial infection in 2009 H1N1 influenza
    Ahn, Shin, Kim, Won Young, Kim, Sung-Han, Hong, SangBum, Lim, Chae-Man, Koh, YounSuck, Lim, Kyung Soo, Kim, Won · 2011 · Influenza and Other Respiratory Viruses
  98. The contributions of lung macrophage and monocyte heterogeneity to influenza pathogenesis
    Mubing Duan, Margaret L. Hibbs, Weisan Chen · 2016 · Immunology and Cell Biology
  99. Inflammation as a Modulator of Host Susceptibility to Pulmonary Influenza, Pneumococcal, and Co-Infections
    Elizabeth R. Aguilera, Laurel L. Lenz · 2020 · Frontiers in Immunology
  100. Spatial-temporal excess mortality patterns of the 1918–1919 influenza pandemic in Spain
    Gerardo Chowell, Anton Erkoreka Barrena, Cecile G. Viboud, Beatriz Echeverri Dávila · 2014 · BMC Infectious Diseases